A higher baseline HIV viral load increases the odds of an immunologic response in women living with HIV, except among those ...

Researchers from Cornell and Northwestern universities have developed a rapid, cell-free method for building nanoparticle ...

Researchers at MIT and other institutions have identified compounds that can fight off viral infection by activating a ...

The World Health Organization now recommends lenacapavir, a twice-yearly injectable HIV prevention drug, especially for high-risk groups. This endorse ...

WHO director general Tedros Adhanom Ghebreyesus says this new drug—which only needs to be injected twice a year—is the next ...

In the ongoing fight against HIV, scientists have taken a new step toward long-term control of the virus. Researchers have ...

Creating a Promising and Novel Molecule In their research, Professor Gauthier's team studied two natural molecules: betulinic ...

In order to meet the biological constraints, In this paper we consider a system of four equations which captures T-cell-HIV interactions. It describes the behavior of normal T cells, latently-infected ...

Second, while the bioinformatic analysis compared "Uninfected" and "HIV-1-infected" cells from patients, the authors could have strengthened their findings by incorporating publicly available ...

In this study, we aimed to characterize the viral reservoir and HIV-specific CD8+ T-cell responses in participants of the Netherlands Cohort Study on Acute HIV Infection (NOVA study), who initiated ...